PD-1, S-100 and CD1a expression in pseudolymphomatous folliculitis, primary cutaneous marginal zone B-cell lymphoma (MALT lymphoma) and cutaneous lymphoid hyperplasia

J Cutan Pathol. 2015 Jan;42(1):6-15. doi: 10.1111/cup.12440. Epub 2014 Dec 11.

Abstract

Background: Pseudolymphomatous folliculitis is a lymphoid proliferation that clinically and histopathologically mimics primary cutaneous extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In this study, we assessed the diagnostic value of three immunohistochemical markers, programmed death-1 (PD-1), CD1a and S100.

Methods: We evaluated 25 cases of cutaneous lymphoid proliferations with established diagnoses, including 9 patients with pseudolymphomatous folliculitis, 11 with MALT lymphoma, and 5 with cutaneous lymphoid hyperplasia (CLH). The clinical, histopathologic and immunohistochemical characteristics were reviewed and three major characteristics assessed: (a) proportion of T cells expressing PD-1, (b) pattern of expression of CD1a by dendritic cells and (c) pattern of expression of S100 by dendritic cells.

Results: We found pseudolymphomatous folliculitis to have a significant increase in PD-1+ T cells compared with MALT lymphoma (p < 0.0001). The pattern of CD1a staining is also informative: MALT lymphoma is significantly more likely to demonstrate a peripheral concentration of CD1a+ dendritic cells around lymphoid nodules than pseudolymphomatous folliculitis (p < 0.0003) or CLH (p < 0.05). Pseudolymphomatous folliculitis demonstrates an interstitial distribution of CD1a+ cells more often than MALT lymphoma (p < 0.04). S100 staining was not a helpful discriminator.

Conclusions: Histopathologic factors including PD-1 and CD1a staining patterns may allow for more certainty in distinguishing lymphoid hyperplasia, including pseudolymphomatous folliculitis, from MALT lymphoma.

Keywords: CD1a; MALT lymphoma; PD-1; lymphoid hyperplasia; pseudolymphomatous folliculitis.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antigens, CD1 / biosynthesis*
  • Biomarkers, Tumor / biosynthesis
  • Diagnosis, Differential
  • Female
  • Humans
  • Immunohistochemistry
  • Lymphoma, B-Cell / diagnosis
  • Lymphoma, B-Cell / metabolism*
  • Lymphoma, B-Cell / pathology
  • Lymphoma, B-Cell, Marginal Zone / diagnosis
  • Lymphoma, B-Cell, Marginal Zone / metabolism*
  • Lymphoma, B-Cell, Marginal Zone / pathology
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Programmed Cell Death 1 Receptor / biosynthesis*
  • Pseudolymphoma / diagnosis
  • Pseudolymphoma / metabolism*
  • Pseudolymphoma / pathology
  • S100 Proteins / biosynthesis*
  • Skin Diseases / diagnosis
  • Skin Diseases / metabolism*
  • Skin Diseases / pathology
  • Skin Neoplasms / diagnosis
  • Skin Neoplasms / metabolism*
  • Skin Neoplasms / pathology
  • Young Adult

Substances

  • Antigens, CD1
  • Biomarkers, Tumor
  • CD1a antigen
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor
  • S100 Proteins